Long-term survival and successful pregnancy in a Nigerian woman with concurrent diagnosis of non-Hodgkin lymphoma and chronic myeloid leukemia: a case report.
증례보고
1/5 보강
[BACKGROUND] Managing synchronous cancers can be complex, often requiring multiple agents, which increases the risk of adverse drug reactions that could negatively impact patient survival.
APA
Ahmed IO, Ogunrinde VO, et al. (2026). Long-term survival and successful pregnancy in a Nigerian woman with concurrent diagnosis of non-Hodgkin lymphoma and chronic myeloid leukemia: a case report.. Journal of medical case reports, 20(1), 41. https://doi.org/10.1186/s13256-025-05773-3
MLA
Ahmed IO, et al.. "Long-term survival and successful pregnancy in a Nigerian woman with concurrent diagnosis of non-Hodgkin lymphoma and chronic myeloid leukemia: a case report.." Journal of medical case reports, vol. 20, no. 1, 2026, pp. 41.
PMID
41572382 ↗
Abstract 한글 요약
[BACKGROUND] Managing synchronous cancers can be complex, often requiring multiple agents, which increases the risk of adverse drug reactions that could negatively impact patient survival. The risk of chemotherapy-induced infertility may also be higher, making pregnancy nearly impossible. The aim is to report long-term survival and successful pregnancy in a 30-year-old Nigerian woman with synchronous BCR::ABL1 positive chronic myeloid leukemia and B-cell non-Hodgkin lymphoma.
[CASE PRESENTATION] The patient is a 30-year-old Nigerian woman referred by a general practitioner with a diagnosis of synchronous BCR::ABL1 positive chronic phase chronic myeloid leukemia and B-cell non-Hodgkin lymphoma. The patient was managed concurrently with a combination of R-CHOP and imatinib mesylate and achieved remission; 5 years into therapy, the patient was lost to follow-up, only to present to the clinic 2 years later with a 1-month-old baby boy. Re-evaluation showed a loss of hematological and molecular remission in chronic myeloid leukemia but not in non-Hodgkin lymphoma. Breastfeeding was stopped and then resumed on imatinib. She subsequently went into remission and is currently doing well on imatinib.
[CONCLUSION] Although managing multiple cancers in an individual may be challenging, we reported long-term survival and successful pregnancy in a 30-year-old Nigerian woman with concurrent chronic myeloid leukemia and non-Hodgkin lymphoma.
[CASE PRESENTATION] The patient is a 30-year-old Nigerian woman referred by a general practitioner with a diagnosis of synchronous BCR::ABL1 positive chronic phase chronic myeloid leukemia and B-cell non-Hodgkin lymphoma. The patient was managed concurrently with a combination of R-CHOP and imatinib mesylate and achieved remission; 5 years into therapy, the patient was lost to follow-up, only to present to the clinic 2 years later with a 1-month-old baby boy. Re-evaluation showed a loss of hematological and molecular remission in chronic myeloid leukemia but not in non-Hodgkin lymphoma. Breastfeeding was stopped and then resumed on imatinib. She subsequently went into remission and is currently doing well on imatinib.
[CONCLUSION] Although managing multiple cancers in an individual may be challenging, we reported long-term survival and successful pregnancy in a 30-year-old Nigerian woman with concurrent chronic myeloid leukemia and non-Hodgkin lymphoma.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Adult
- Female
- Humans
- Pregnancy
- Antineoplastic Combined Chemotherapy Protocols
- Cyclophosphamide
- Doxorubicin
- Imatinib Mesylate
- Leukemia
- Myelogenous
- Chronic
- BCR-ABL Positive
- Lymphoma
- Non-Hodgkin
- Neoplasms
- Multiple Primary
- Nigeria
- Prednisone
- Pregnancy Complications
- Neoplastic
- Pregnancy Outcome
- Rituximab
- Vincristine
- Chronic myeloid leukemia
… 외 2개
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.